Dr. Gleason has greater than 35 years experience in basic research and management of clinical trials for medical devices. He has extensive experience in design control, product development requirements and regulatory submissions for both the U.S. and international markets. In addition to the overall management of FRS, Dr. Gleason has also served as the medical monitor on numerous ophthalmic clinical studies as well as a product development and regulatory strategy consultant to the ophthalmic industry.
Prior to establishing Foresight Regulatory Strategies, Inc., Dr. Gleason was Vice President, Quality Assurance and Regulatory Affairs with global regulatory responsibility for Polymer Technology Corporation (affiliate of Bausch & Lomb) and soft lens material registrations for Bausch & Lomb. Dr. Gleason had oversight responsibility for successful submissions of IDE's, PMA's, 510(k)s, PMA supplements, ISO 9001/46001 certification (CE marking) and international product registrations. He has been a member of both ANSI and ISO committees for the development of medical device standards.
Dr. Gleason has been a speaker at numerous U.S. and international symposia and conferences and regularly lectures at the New England College of Optometry.
Dr. Gleason received his B.S. from the University of Massachusetts, Amherst and his Doctor of Optometry from the Massachusetts College of Optometry.